Ishita Gupta1, Gheyath K Nasrallah2, Anju Sharma1, Ayesha Jabeen1, Maria K Smatti2, Hamda A Al-Thawadi1, Ali A Sultan3, Moussa Alkhalaf4, Semir Vranic5, Ala-Eddin Al Moustafa6,7. 1. College of Medicine, QU Health, Qatar University, Doha, Qatar. 2. Biomedical Research Centre, Qatar University, Doha, Qatar. 3. Weill-Cornell Medicine-Qatar, Doha, Qatar. 4. Faculty of Medicine, Kuwait University, Kuwait City, Kuwait. 5. College of Medicine, QU Health, Qatar University, Doha, Qatar. semir.vranic@gmail.com. 6. College of Medicine, QU Health, Qatar University, Doha, Qatar. aalmoustafa@qu.edu.qa. 7. Biomedical Research Centre, Qatar University, Doha, Qatar. aalmoustafa@qu.edu.qa.
Correction to: Cancer Cell Int (2020) 20:107 https://doi.org/10.1186/s12935-020-01190-2
In this article [1], there was a copy pasting error of the PCR image of the representative data provided in Figures 1 and 2. The corrected figures are published with this erratum (Figs. 1 and 2).
Fig. 1
Representative PCR for low-risk HPV-subtypes in 15 different EBV-positive and EBV-negative healthy blood donors
Fig. 2
Representative PCR for high-risk HPV-subtypes in 15 different EBV-positive and EBV-negative samples of healthy blood donors
Representative PCR for low-risk HPV-subtypes in 15 different EBV-positive and EBV-negative healthy blood donorsRepresentative PCR for high-risk HPV-subtypes in 15 different EBV-positive and EBV-negative samples of healthy blood donors
Authors: Ishita Gupta; Gheyath K Nasrallah; Anju Sharma; Ayesha Jabeen; Maria K Smatti; Hamda A Al-Thawadi; Ali A Sultan; Moussa Alkhalaf; Semir Vranic; Ala-Eddin Al Moustafa Journal: Cancer Cell Int Date: 2020-04-03 Impact factor: 5.722